VVOS - Vivos Therapeutics Inc. (VVOS) CEO Kirk Huntsman on Q1 2022 Results - Earnings Call Transcript
Vivos Therapeutics, Inc. (VVOS) Q1 2022 Earnings Conference Call May 16, 2022 05:00 p.m. ET Company Representatives Kirk Huntsman - Chairman, Chief Executive Officer Brad Amman - Chief Financial Officer Julie Gannon - Investor Relations Officer Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Scott Henry - ROTH Capital Steve Kruger - Foresight Investing Presentation Operator Good day, everyone and welcome to the Vivos Therapeutics Incorporated First Quarter 2022 Earnings Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow management’s remarks. This conference call is being recorded and a replay of today’s call will be available on the Investor Relations section of Vivos’ website and will remain posted there for the next 30 days. I will now hand the call over to Julie Gannon, Vivos’ Investor Relations Officer for introductions and the reading of the Safe Harbor statement. Please go ahead. Julie
For further details see:
Vivos Therapeutics, Inc. (VVOS) CEO Kirk Huntsman on Q1 2022 Results - Earnings Call Transcript